focus -WSS

focus

author：hotspot 2025-09-30 09:29:45 - browse：347

ITeos Therapeutics offered the first look at clinical data for its experimental cancer antibody that works by blocking the novel — and very buzzworthy — protein target called TIGIT.

The tumor-shrinking activity of the company’s drug, called EOS-448, was minimal but still comparable to early study data from competing TIGIT-targeted drugs in development, including ones from Roche and Merck.

iTeos presented the EOS-448 Phase 1 study results at the annual meeting of the American Association for Cancer Research on Saturday.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： India sets sights on home

focus

WSS

Neuroscience renaissance leads to new crop of psychiatric drugs

Neuroscience renaissance leads to new crop of psychiatric drugs

TikTok cracks down on users posting about weight loss drugs

Children’s Hospital revives plan for pedestrian bridge

The kidney, in all its complexity, is captured in a new atlas

Seattle police shoot person suspected in downtown stabbing

Wikipedia

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Virginia high school admissions case could be legal follow

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Drug repurposing or repositioning? The language matters

NEJM study measures Covid brain fog, impact on IQ

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CDC panel: People 65 and older should get a Covid spring booster shot

How to save PrEP access — and even expand it

Stanford updates investigation of president’s past research

What does generative AI mean for health care? We asked experts

Why the Crimean Bridge is key to Russia's war in Ukraine

hotspot

STAT Madness 2024: Meet the contenders

Man who had jail sentence commuted by Trump arrested again

Celebrate National Dole Whip Day for 3 days this week at Disney

Ebola public health emergency is over, WHO declares

Plane’s emergency slide plummets from sky, hits Chicago home

Childhood vaccination ad campaign launches in the U.K.

focus

focus

hotspot

knowledge